Validity and reliability of the EQ-5D-3L (a generic preference-based instrument used for calculating quality-adjusted life -years) for patients with type 2 diabetes in Iran
Publication date: Available online 14 January 2021Source: Diabetes & Metabolic Syndrome: Clinical Research & ReviewsAuthor(s): Forouzan Zare, Hosein Ameri, Farzan Madadizadeh, Mohammad Reza Aghaei
Source: Diabetes and Metabolic Syndrome: Clinical Research and Reviews - Category: Endocrinology Source Type: research
More News: Diabetes | Diabetes Type 2 | Endocrinology | Iran Health | Metabolic Syndrome | Middle East Health